Browse the full directors' dealings record of 인트론바이오, a listed equity based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Healthcare sector, 인트론바이오 has published 1 reports. Market capitalisation: €95.3bn. The latest transaction was disclosed on 19 March 2026 — Sale. Among the most active insiders: 전수연. All data is free.